ASENAPINE
Generic: ASENAPINE MALEATE
Breckenridge PharmaceuticalManufacturer
SUBLINGUALRoute
ASENAPINE MALEATEActive Substance
2021-03-09Original Approval
ASENAPINE is FDA application ANDA205960, sponsored by BRECKENRIDGE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2021-04-19
Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavori
Class III2021-04-19
Asenapine Sublingual Tablets, 10 mg, Rx only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020, NDC 42794Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavori
Top Reported Reactions
1
DRUG INEFFECTIVE
223 reports
2
TOXICITY TO VARIOUS AGENTS
161 reports
3
OFF LABEL USE
138 reports
4
SUICIDE ATTEMPT
115 reports
5
WEIGHT INCREASED
114 reports
6
DRUG INTERACTION
106 reports
7
AKATHISIA
104 reports
8
PRODUCT USE IN UNAPPROVED INDICATION
90 reports
9
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
85 reports
10
COMPLETED SUICIDE
81 reports